NRP1 and neoplasm: NRP1 has been described lately as a potential target for immune checkpoint inhibition (Chuckran et al., 2020), specifically due to its association with Treg (regulatory T) cells in the tumor microenvironment (Chuckran et al., 2021) [53,54].